Mashima, T., Iwasaki, R., Kawata, N., Kawakami, R., Kumagai, K., Migita, T., . . . Seimiya, H. (2019). In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells. Br J Cancer.

Mashima, Tetsuo, Risa Iwasaki, Naomi Kawata, Ryuhei Kawakami, Koshi Kumagai, Toshiro Migita, Takeshi Sano, Kensei Yamaguchi, a Hiroyuki Seimiya. "In Silico Chemical Screening Identifies Epidermal Growth Factor Receptor As a Therapeutic Target of Drug-tolerant CD44v9-positive Gastric Cancer Cells." Br J Cancer 2019.

Mashima, Tetsuo, et al. "In Silico Chemical Screening Identifies Epidermal Growth Factor Receptor As a Therapeutic Target of Drug-tolerant CD44v9-positive Gastric Cancer Cells." Br J Cancer 2019.